This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Duke University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Qing Cheng - Innovator in Transplant Rejection Monitoring
Introduction
Qing Cheng is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of transplant medicine, particularly in the area of monitoring acute rejection.
Latest Patents
Qing Cheng holds a patent titled "Gene signatures for monitoring acute rejection and methods of using same." This patent provides methods and compositions for detecting and treating acute transplant rejection, showcasing his innovative approach to improving patient outcomes.
Career Highlights
Qing Cheng is affiliated with Duke University, where he conducts research and develops new methodologies in the field of transplant medicine. His work is instrumental in advancing the understanding of acute rejection and its management.
Collaborations
One of his notable collaborators is Eileen Chambers, who contributes to the research efforts alongside Cheng.
Conclusion
Qing Cheng's work in developing gene signatures for monitoring acute transplant rejection represents a significant advancement in medical science. His contributions are vital for improving transplant success rates and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile